Medirom Healthcare Technologies Inc. (NASDAQ:MRM – Get Free Report) saw a significant decline in short interest in the month of October. As of October 30th, there was short interest totaling 9,002 shares, a decline of 69.9% from the October 15th total of 29,941 shares. Based on an average trading volume of 65,435 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the shares of the company are short sold.
Medirom Healthcare Technologies Price Performance
NASDAQ MRM traded up $0.00 during trading hours on Friday, hitting $0.29. The company had a trading volume of 6,986 shares, compared to its average volume of 255,285. Medirom Healthcare Technologies has a fifty-two week low of $0.24 and a fifty-two week high of $2.33. The business has a fifty day simple moving average of $0.55 and a 200-day simple moving average of $0.99.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Medirom Healthcare Technologies in a report on Tuesday, August 25th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat, the stock presently has a consensus rating of “Sell”.
View Our Latest Analysis on Medirom Healthcare Technologies
Medirom Healthcare Technologies Company Profile
Medirom Healthcare Technologies Inc. is a Japan-based healthcare and wellness company that provides services designed to support relaxation, physical conditioning and preventative health. The company operates through a network of wellness salons and related healthcare businesses, serving consumers primarily in Japan. Its principal salon brand, Re.Ra.Ku, offers services such as body care, stretching, reflexology and other relaxation treatments. Medirom serves customers through company-operated and franchised locations, with its services focused on helping clients manage fatigue, improve flexibility and maintain general physical well-being.
See Also
- Five stocks we like better than Medirom Healthcare Technologies
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Medirom Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medirom Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
